SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-007396
Filing Date
2020-02-27
Accepted
2020-02-27 16:25:29
Documents
14
Period of Report
2020-02-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K myok-8k_20200227.htm   iXBRL 8-K 41313
2 EX-99.1 myok-ex991_32.htm EX-99.1 222080
3 GRAPHIC guaf4krqlmif000001.jpg GRAPHIC 17233
  Complete submission text file 0001564590-20-007396.txt   428383

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA myok-20200227.xsd EX-101.SCH 5972
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20200227_lab.xml EX-101.LAB 18708
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20200227_pre.xml EX-101.PRE 11176
9 EXTRACTED XBRL INSTANCE DOCUMENT myok-8k_20200227_htm.xml XML 3410
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 20662466
SIC: 2834 Pharmaceutical Preparations